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Summary The physiology of the multidrug transporter P-glycoprotein (Pgp) is still poorly understood. We
now show evidence that cell lines with a high expression of Pgp display a reduced accumulation of cortisol and
an ATP-dependent outward transport of the hormone. Cortisol efflux from Pgp negative cells does not have
such an active component. Further we show that the steroid hormones cortisol, testosterone, and progesterone
cause an immediate, dose-dependent increase of daunorubicin accumulation in Pgp overexpressing cells. These
effects are particularly apparent for the more lipophilic steroids.
These results demonstrate that Pgp may function as a transporter for cortisol and suggest a physiological
role of the protein in steroid handling by organs such as the adrenal.
P-glycoprotein (Pgp), encoded by the mdrl gene is an integral
membrane protein, that functions as an ATP hydrolysis-
dependent transporter with broad specificity of certain anti-
cancer drugs out of tumour cells (Endicott & Ling, 1989;
Broxterman et al., 1988; Chen et al., 1986). The increased
drug efflux caused by overexpression of Pgp leads to a
decreased steady-state drug accumulation in tumour cells,
making them resistant to the drugs involved (Hammond et
al., 1989). This type of resistance to multiple drugs is called
multidrug resistance (MDR). High expression of Pgp has
also been found in a number of normal tissues. The peculiar
tissue distribution with elevated levels of Pgp in liver, kidney,
jejunum and colon, suggests a role of Pgp in active transport
of hydrophobic compounds originating from the diet into
bile, urine and directly into the gastrointestinal tract (Gottes-
man & Pastan, 1988; Van der Valk et al., 1990). Interest-
ingly, Pgp is also highly expressed in hormone secreting
organs, like the adrenal gland (Gottesman & Pastan, 1988),
the trophoblast of the human placenta (Sugawara et al.,
1988a) and is induced in the uterine secretory epithelium of
the mouse by a combination of estrogen and progesterone
(Arceci et al., 1990), which suggests a role of Pgp during
pregnancy. Further indications for a specialised role in the
physiology of steroid hormones come from the observation
of a strong Pgp expression in the human adrenal cortex, but
weak or no staining in the adrenal medulla (Van der Valk et
al., 1990; Sugawara et al., 1988b).
It has been hypothesised that steroids might be transported
by Pgp out of the adrenal cortical cells and also concentrated
again in specific tissues such as in the endometrium by Pgp
expressing luminal plasma membranes. In support of an
interaction of progesterone and cortisol with Pgp it has been
shown that these steroids inhibit [3H]-azidopine photoaffinity
labeling of Pgp (Yang et al., 1989) and that progesterone
itself can specifically bind to Pgp (Qian et al., 1990). In
addition progesterone has been shown to impair Pgp
mediated vinblastine efflux from murine MDR cells (Yang et
al., 1990). In the latter study (Yang et al., 1990) progesterone
itself could not be shown to be transported by Pgp.
Here we report studies on the interaction of the less hyd-
rophobic steroid hormone cortisol with Pgp and provide




DC-3F transformed hamster lung cells and the highly drug
resistant DC-3F/ADX derivative (gift from Dr J.L. Biedler)
and A2780 human ovarian carcinoma cells and the drug
resistant variant 2780AD (gift from Dr R.F. Ozols) were
grown in Eagle's modified Dulbecco's minimal essential
medium, buffered with bicarbonate and 20 mM Hepes and
supplemented with 7.5% FCS (Gibco Europe, Paisley, Scot-
land) in a humidified atmosphere with 5-6% CO2 at 37°C
and subcultured by short trypsinisation upon reaching
confluence (Broxterman et al., 1990). Drug-resistant cells
were cultured in drug-free medium for 48 h before the
experiments.
Chemicals
[1,2-3H(N)J-cortisol (49.1 Ci mmol 1) was obtained from
NEN-Du Pont (Dreiech, Germany). Unlabelled steroids
(Sigma, St. Louis, MO; Merck, Darmstadt, Germany) were
dissolved in absolute ethanol (10 mM) and stored at 4°C.
Cyclosporin A (in the formulation of SandimmuneR) and
SDZ PSC 833 were a gift of Sandoz BV (Uden, The Nether-
lands). PSC 833, ([3'-keto-Bmt']-[Vall-cyclosporin), which is
a very potent MDR reversing agent (Gaveriaux et al., 1991)
was dissolved in absolute ethanol. Daunorubicin.HCI
(CerubidinR) was from Rhone-Poulenc (Amstleveen, The
Netherlands) and verapamil.HCI from Sigma (St. Louis,
MO).
Cellular cortisol accumulation andefflux
Cells (2 x 106 cells ml-') were incubated with 1 JM 3H-
cortisol at 37°C in medium A (growth medium buffered with
20 mM Hepes, pH= 7.4, supplemented with 10% FCS) or
medium C (medium A without glucose, with added 10mM
sodium azide and 1 mg ml1 2-deoxy-d-glucose). By incuba-
tion in medium C, cellular ATP is depleted to 10-15% of
initial concentration within 15 min (Versantvoort et al.,
1992). After incubation, the cells were washed twice with
ice-cold medium and then transferred to liquid scintillation
fluid and radioactivity was counted.
For cortisol efflux studies, the cells were first incubated
with 1 fLM 3H-cortisol for 30 min in medium C (pH = 7.4) at
37°C, pelleted and rapidly washed once with fresh, ice-cold
medium. Then the cells were resuspended in 1 ml cold
medium and quadruplicate samples were taken to determine
the zero-time values for the efflux curves. Seven hundred and
fifty pl of the cell suspension was then added to 6.75 ml efflux
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medium of 37°C to start the cortisol efflux. Every 5 s a
sample was pipetted out in cold wash medium and pelleted
immediately. Cell-associated 3H-cortisol was measured subse-
quently after transfer of the cells to liquid scintillation fluid.
To examine the effects of Pgp blocking agents on cortisol
efflux, cells were loaded with medium A + 64lM cyclosporin
A (Sandimmune) and effluxed in the same medium. In
preliminary experiments we found that 64ylM cyclosporin A
or 8iLM PSC 388 readily inhibited Pgp mediated
daunorubicin (DNR) efflux from DC3-F/ADX cells (not
shown).
Effect ofsteroids on daunorubicin accumulation
The effect of steroid hormones on cellular DNR accumula-
tion was measured in a dynamic way in a flow-through
system, as described earlier (Lankelma et al., 1990; Spoelstra
et al., 1991). In this system 5-10 x 106 2780AD MDR or
A2780 drug sensitive cells were allowed to attach to the glass
bottom plate overnight under normal growth conditions. An
HPLC pump, equipped for micro-liquid chromatography
(Gilson, Villiers-Le-Bel, France) was used to pump DNR
containing medium A with 5% FCS over the monolayer of
cells. DNR fluorescence in the medium was continuously
monitored at the outlet of the flow-through system by a
fluorescence monitor (model 3000, Perkin-Elmer, Norwalk,
CT) at excitation/emission wavelengths of 480/560 nm. The
cells were allowed to equilibrate until a steady-state signal of
DNR was reached. Then a series of six pulses of the studied
steroid was injected every 30 s into the flowing medium (flow
rate 200 ll min-') via an HPLC injection valve, resulting in
concentrations present above the cells as indicated. In
Figures 1 and 2 the estimated concentration of steroid at the
outlet of the flow-cell is given. The starting concentration at
the inlet is about three times higher. In the same way,
injections of verapamil, resulting in a concentration of app-
roximately 25- 75 Zm verapamil in the medium overflowing
the cells, known to exert maximal effects in this system on
DNR accumulation in 2780AD cells (Spoelstra et al., 1991),
were used as a positive control MDR modifier. An increase
of DNR accumulation in the cells causes a concomitant
decrease in extracellular DNR fluorescence, represented by a
dip in the steady-state level seen by fluorescence monitoring
at the outlet of the flow-through system. The increase in
extracellular DNR after the initial dip as seen in MDR cells
(Figures 2 and 3) reflects an increased efflux of DNR after
disappearance of the modifying drug or hormone.
Results
A number of steroids synthesised along the metabolic path-
ways in the human adrenal were studied. The immediate
effects of these steroids on DNR accumulation in 2780AD
cells were monitored in a flow-through system to study their
interaction with Pgp. In 2780AD cells an increase in intracel-
lular DNR concentration was observed for all steroids studi-
ed except for aldosterone. However, both depth and shape of
the time-curves varied considerably among the steroid hor-
mones. Time-curves representative for the different shapes
observed are shown in Figure 1.
A qualitative correlation was found between the lipophili-
city of the steroids and the depth of the dip observed after
their injection. The latter parameter can be seen as a relative
measure of immediate DNR pumping inhibition. The order
of lipophilicity of the most important steroids studied here is
progesterone>testosterone>cortisol>aldosterone. The octa-
nol/water partition coefficient for these steroids are 124, 61,
12.6 and not studied resp., according to Giorgi and Stein
(1981).
The largerst effects were observed for the aldosterone pre-
cursors progesterone, corticosterone and 11-deoxy-cortico-
sterone and for the cortisol precursor 11-deoxy-cortisol.
Intermediate effects were observed for 17-hydroxy-progester-
Cortisol Testosterone Progesterone
Time = 5 min.
Figure 1 Effect of verapamil and several steroid hormones on steady-state daunorubicin accumulation in 2780 cells as recorded in
the flow-through experiment. Representative time-curves after pulse-injections (arrows) of hormones are shown. Verapamil
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Figure 2 Effect of increasing concentrations of progesterone on steady-state daunorubicin accumulation in 2780 cells as measured
in the flow-through experiment. A representative experiment is shown. Progesterone concentrations after pulse-injections (arrows)
indicated are estimated concentrations at the outlet of the flow-through system, as explained in the Methods sections.
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Figure 3 Efflux of cellular cortisol after loading DC3-F cells with 1 JlM cortisol (set at 100%) and incubation in cortisol-free
medium for the indicated times. Efflux in medium A (U-U), medium C (A-A) or medium A + 64iLM cyclosporin (-*).
Data are from a representative experiment; inset: linear regression curves. TI/2 values are in Table II.
one and for the androgens dehydroepiandrosterone, andro-
stenedione and testosterone, while cortisol and cortisone
showed small effects. Aldosterone showed no effect at all.
Small effects of lower concentrations of the steroids on cel-
lular DNR uptake, also correlating with lipophilicity were
observed in drug sensitive A2780 cells (Figure 1). However,
further increasing the concentration of the steroids did not
result in an increase of the effect in A2780 cells, as is shown
for progesterone in Figure 2, whereas in 2780AD cells a
dose-dependent effect was observed.
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Subsequently we have studied the interaction of some of
the steroid hormones with Pgp by measuring their accumula-
tion in sensitive and Pgp/MDR cells. First the steroids with
extreme polarity values, aldosterone and progesterone were
studied. We could not reliably measure cellular accumulation
of progesterone as reported by Yang et al. (1990), who could
not obtain evidence for Pgp mediated progesterone efflux,
possibly because such an extremely hydrophobic compound
has a rapid passive diffusion rate across the plasma memb-
rane. For aldosterone no significant difference in cellular
accumulation between sensitive and Pgp/MDR cells was
found (not shown). Another steroid hormone, that might be
actively transported by Pgp is cortisol, because it is more
hydrophilic than progesterone, but less hydrophilic than
aldosterone (Giorgi & Stein, 1981). We therefore studied the
energy-dependence of cortisol transport in the highly Pgp
expressing cell line, DC3-F/ADX (resistance factor for actin-
omycin D is 10,000; Biedler et al., 1988). In preliminary
experiments we determined that the steady-state accumula-
tion of cortisol in parent and Pgp expressing cells was
reached within 15 min, while similar results were obtained
upon longer incubation times. The results (Table I) showed
that cortisol accumulation in DC3-F/ADX cells was about
30% of that in the parent cells. 2780AD cells accumulated
about 65% cortisol compared to the parental A2780 cells.
For the typical MDR drug DNR these values were 15%
(DNR accumulation in DC3-F was 102, and in DC3-F/ADX
15 pmol 106 cells, at 0.51JM DNR concentration) and 9%
(2780AD compared to A2780, Broxterman et al., 1988).
Further the cortisol accumulation in DC3-F/ADX was
highly increased (to 800%) by adding 8JAM SDZ PSC 833 or
(to 750%) by depleting cellular ATP levels below the level
needed for proper Pgp function (Broxterman & Pinedo,
1991). In a separate experiment it was found that 16 JAM
verapamil as well as 8 JlM cyclosporin A increased cortisol
steady-state accumulation with about 300%.
In DC3-F cells the cortisol accumulation increased 2-fold
under these conditions. In 2780AD cells the cortisol
accumulation was doubled with 8 JM PSC 833 or ATP deple-
tion, while no effect was seen in A2780.
To study cortisol efflux we loaded DC3-F and DC3-F/
ADX cells with cortisol in medium C or medium A + 64JAM
cyclosporin A to obtain equal cellular steady-state levels of
cortisol (see Table I). The retention of cortisol in the cells
was then measured upon incubation in medium A, C, or










Table I Steady-state cortisol accumulation
Medium A +
Medium A 81AM PSC833 Medium C C:A x 100%
DC-3F 1.3±0.5a 3.1±1.4 2.8±0.1 = 215%
DC3-F/ADX 0.4±0.2 3.3±0.5 3.0±0.0 = 750%
A2780 3.1±0.5 3.0±0.2 2.7±0.1 = 87%
2780AD 2.0±0.7 3.4±0.6 3.6±0.6 = 180%
aResultsareexpressedinpmol/106cellsand are means±s.d. of60 min
cortisol accumulation values of 3-5 (medium A) or 2 (medium C)
independent experiments (each in quadruplicate). Cortisol concentra-
tion was 1 LLM.
the latter drug instead of PSC 833, because of a limited
supply of PSC 833. A higher concentration of cyclosporin A
is needed, because PSC 833 is about 10-fold more potent
than cyclosporin A in reversing MDR (Gaveriaux et al.,
1991). In Figures 3 and 4 and Table II it is shown that
cortisol efflux is slowed down by energy-depletion or by the
presence of cyclosporin A in the efflux medium in DC3-F/
ADX, but not in DC3-F cells. The tl/2 values of the cortisol
elimination from the cells as determined from the initial part
of the semilogarithmically plotted data (see insert Figures 3
and 4) are compiled in Table II. When the cells were loaded
in medium A with 8 JAM cortisol instead of medium C with
1 JAM cortisol (both giving similar intracellular cortisol con-
centrations), the tl/2 values for cortisol efflux from DC3-F/
ADX in medium A were still about 3-fold shorter (not
shown). These very rapid efflux values can however not be
determined with great precision. This result was to be
expected because after loading in medium C it may take a
few seconds in medium A for ATP levels to recover
sufficiently to fully support Pgp mediated efflux. In accor-
dance with this explanation, loading of DC3-F cells in
medium A or C made no difference for the T1/2 of apparent
cortisol efflux (not shown), again suggesting its passive
nature.
Discussion
Although a role of Pgp in the active transport of steroid
hormones was postulated, there was no experimental evi-
dence to support it sofar.
We have now shown in an on-line detection system (Lan-
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Figure 4 Efflux of cellular cortisol after loading DC3-F/ADX cells with 1 JLM cortisol and incubation in cortisol-free medium. For
details see legend Figure 3.288 C.K. VAN KALKEN et al.
Table II Tl/2 values for cortisol efflux
Medium A + 64iLM
Medium A Sandimmune Medium C
DC3-F 10.2± 0.2a 13.0±0.7 9.6± 1.1
DC3-F/ADX 10.1±2.0 20.2±4.8 20.0±4.2
aT1/2values (s) arecalculated bylinear regression ofthe0-30 sefflux
curves (see inset Figures 3 and 4) and are means±s.d. from two
independent experiments.
kelma et al., 1990) that steroid hormones have an immediate
effect on cellular DNR accumulation, somewhat proportional
to the hydrophobicity of the steroids. From the difference in
effect on parent and Pgp expressing 2780 cells at higher
concentrations of steroids and the dose-dependence in
2780AD Pgp/MDR cells only it is likely that a net increase in
DNR uptake in the Pgp expressing cells occurs via a (direct
or indirect) steroid interaction with Pgp.
Evidence for a direct interaction of cortisol and proges-
terone with Pgp comes from the study of Yang et al. (1989)
who showed that both these steroids effectively inhibited
[3H]-azidopine binding to Pgp from MDR cells as well as
from the endometrium of gravid mouse uterus while aldo-
sterone had no effect. The latter hormone also had no effect
in our experiments. However, none of these experiments
showed direct evidence for actual Pgp-mediated transport of
one of the steroid hormones.
Based on the experiments discussed above we chose corti-
sol and progesterone to further study the proposed role of
the Pgp associated efflux pump in steroid hormone transport.
For comparison aldosterone, was studied. Our approach was
to study the hormone accumulation and efflux in cell lines
with different Pgp levels and to take the energy-dependence
and reversibility with Pgp blockers of these parameters as
criteria for the involvement of active (ATP-dependent) trans-
port (Gross et al., 1970). Besides the already mentioned 2780
cells we have used the DC3-F/ADX cells which have a very
high Pgp expression. For comparison the parent DC3-F cells
which have some pgpl expression (Devine et al., 1991) were
studied.
Our results show a decreased steady-state accumulation of
cortisol in DC3-F/ADX cells, which was reversible upon
energy depletion and by the cyclosporin analog PSC 833. The
DC3-F parent cell line also displayed an energy-dependent
component of cortisol steady-state accumulation, not seen in
the efflux experiment. Part of this component may be related
to Pgp expression in this cell line, since we also found that
16 JM verapamil caused an increase of the steady-state
accumulation of the typical MDR drug DNR to 200% of
control levels in DC3-F cells. This is in accordance with
results measured for doxorubicin in another low level Pgp
expressing 'parent' cell line, AUXB1 (Schuurhuis et al.,
1990).
However, from the present data the possibility cannot be
excluded that in DC3-F cells there is another non-Pgp related
component, which actively transports cortisol over the
plasma membrane. In the Pgp negative cell line A2780, how-
ever, no such effects were seen, excluding some sort of
general membrane distorting effect of PSC 833 or energy
depletion, affecting cortisol transport. Moreover, cortisol
efflux from preloaded cells which appeared to be very rapid
(tl/2 = 10 s), was partly energy-dependent in DC3-F/ADX
cells only. These results suggest that Pgp can actively trans-
port cortisol through the plasma membrane.
We also found that the passive efflux of cortisol as judged
from the efflux in medium C was slower in DC3-F/ADX
compared to DC3-F. Since it has been found that the perme-
ability coefficient for cortisol can vary easily 2-fold between
different cell lines (Giorgi & Stein, 1981), differences in com-
position of the plasmamembrane might play a role in this
finding.
In contrast to these results for cortisol, we could not
reliably measure progesterone accumulation and therefore
were not able to assess putative differences in progesterone
accumulation between sensitive and MDR cells, in agreement
with data from Yang et al. (1990). This may reflect the
inability to measure active drug efflux of very lipophilic
compounds such as progesterone, since it is readily bypassed
by rapid passive diffusion. For aldosterone we did not find
significant differences in accumulation between sensitive and
MDR cell lines. This result is in line with the absence of
effect of aldosterone on azidopine binding to Pgp (Yang et
al., 1989).
Our results might be of importance in understanding the
physiological role of high Pgp expression in certain tissues.
The adrenal tissue is the tissue with the highest expression of
Pgp in the adult (Sugawara et al., 1988a; Fojo et al., 1987).
We recently have shown that the cells of the foetal zone of
the foetal adrenal cortex do not express Pgp, while cells of
the definitive zone or neocortex of the foetal adrenal cortex
clearly expressed Pgp (van Kalken et al., 1992). Furthermore,
while the foetal zone cells are deficient in the enzyme 3p-
hydroxysteroid dehydrogenase (3p-OHSD) and hence in
mineral- and glucocorticoid production (Doody et al., 1990;
Preston Nelson, 1990), the Pgp expressing neocortex has
markedly higher 3P-OHSD activity and capacity to synthesise
cortisol (Doody et al., 1990).
In conclusion, we have shown that cortisol is transported
in an ATP-dependent way by Pgp-expressing cells. This result
further suggests a role of Pgp in steroid hormone transport in
the human adrenal, possibly to protect the cellular mem-
branes from too high concentrations of toxic steroids.
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